Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Oncoprotein Fra-2 Drives the Activation of Human Endogenous Retrovirus Env Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) Patients. | Cells | 2024 | 39329701 | PubTator, text mining | PubMed |
| Effect of Ritanserin and Duloxetine on the Gene Expression of Primary Aniridia and Healthy Human Limbal Stromal Cells, In Vitro. | Ophthalmol Ther | 2024 | 39306593 | PubTator, text mining | PubMed |
| BertSNR: an interpretable deep learning framework for single-nucleotide resolution identification of transcription factor binding sites based on DNA language model. | Bioinformatics | 2024 | 39107889 | PubTator, text mining | PubMed |
| FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells. | J Neurooncol | 2024 | 39073688 | PubTator, text mining | PubMed |
| Identification of core genes in intervertebral disc degeneration using bioinformatics and machine learning algorithms. | Front Immunol | 2024 | 39050860 | PubTator, text mining | PubMed |
| In vivo vitamin D target genes interconnect key signaling pathways of innate immunity. | PLoS One | 2024 | 39042613 | PubTator, text mining | PubMed |
| Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy. | Cell Commun Signal | 2024 | 39010083 | PubTator, text mining | PubMed |
| Progress in the Study of Fra-2 in Respiratory Diseases. | Int J Mol Sci | 2024 | 39000247 | PubTator, text mining | PubMed |
| TFscope: systematic analysis of the sequence features involved in the binding preferences of transcription factors. | Genome Biol | 2024 | 38987807 | PubTator, text mining | PubMed |
| Multiomic analysis of monocyte-derived alveolar macrophages in idiopathic pulmonary fibrosis. | J Transl Med | 2024 | 38937806 | PubTator, text mining | PubMed |
| Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. | Redox Biol | 2024 | 38861833 | PubTator, text mining | PubMed |
| Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. | Mol Ther Nucleic Acids | 2024 | 38784179 | PubTator, text mining | PubMed |
| BACH1 transcriptionally upregulates FOSL2 to induce M2 macrophages phenotype by activating TGFβ/SMAD signaling to promote the transformation of lung fibroblasts into myofibroblasts. | Tissue Cell | 2024 | 38776730 | PubTator, text mining | PubMed |
| Association of Novel Loci With Keratoconus Susceptibility in a Chinese Genome-Wide Association Study. | Invest Ophthalmol Vis Sci | 2024 | 38767907 | PubTator, text mining | PubMed |
| Associations Between Prenatal Vitamin D and Placental Gene Expression. | bioRxiv | 2024 | 38765981 | PubTator, text mining | PubMed |
| Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc. | Proc Natl Acad Sci U S A | 2024 | 38657045 | PubTator, text mining | PubMed |
| Massively parallel screen uncovers many rare 3' UTR variants regulating mRNA abundance of cancer driver genes. | Nat Commun | 2024 | 38637555 | PubTator, text mining | PubMed |
| Decoding chromatin states by proteomic profiling of nucleosome readers. | Nature | 2024 | 38448585 | PubTator, text mining | PubMed |
| AP-1/C-FOS and AP-1/FRA2 differentially regulate early and late adipogenic differentiation of mesenchymal stem cells. | J Cell Biochem | 2024 | 38440920 | PubTator, text mining | PubMed |
| Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. | Signal Transduct Target Ther | 2024 | 38342897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=8